Caduet in an Untreated Subject Population

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

September 30, 2007

Conditions
HypertensionDyslipidemia
Interventions
DRUG

Caduet

Trial Locations (34)

13901

Pfizer Investigational Site, Binghamton

19020

Pfizer Investigational Site, Bensalem

23510

Pfizer Investigational Site, Norfolk

27103

Pfizer Investigational Site, Winston-Salem

28112

Pfizer Investigational Site, Monroe

30033

Pfizer Investigational Site, Decatur

30309

Pfizer Investigational Site, Atlanta

33027

Pfizer Investigational Site, Pembroke Pines

33137

Pfizer Investigational Site, Miami

33180

Pfizer Investigational Site, Aventura

33308

Pfizer Investigational Site, Fort Lauderdale

37660

Pfizer Investigational Site, Kingsport

39201

Pfizer Investigational Site, Jackson

39202

Pfizer Investigational Site, Jackson

45236

Pfizer Investigational Site, Cincinnati

48023

Pfizer Investigational Site, Fair Haven

48152

Pfizer Investigational Site, Livonia

64024

Pfizer Investigational Site, Excelsior Springs

71111

Pfizer Investigational Site, Bossier City

72204

Pfizer Investigational Site, Little Rock

72401

Pfizer Investigational Site, Jonesboro

76034

Pfizer Investigational Site, Colleyville

76502

Pfizer Investigational Site, Temple

77030

Pfizer Investigational Site, Houston

77702

Pfizer Investigational Site, Beaumont

90806

Pfizer Investigational Site, Long Beach

92780

Pfizer Investigational Site, Tustin

92843

Pfizer Investigational Site, Garden Grove

97404

Pfizer Investigational Site, Eugene

08009

Pfizer Investigational Site, Berlin

07202

Pfizer Investigational Site, Elizabeth

08540

Pfizer Investigational Site, Princeton

08880

Pfizer Investigational Site, South Bound Brook

45406-5144

Pfizer Investigational Site, Dayton

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00332761 - Caduet in an Untreated Subject Population | Biotech Hunter | Biotech Hunter